Clinical Chemistry Analyzers Market

Clinical Chemistry Analyzers Market by Product (Fully-Automated Analyzers, PoC Analyzers, Reagents), Test Type (Basic Metabolic, Liver, Renal, Lipid, Thyroid Function), End User (Hospitals, Clinics, Laboratories, Research) – Global Forecast to 2026

Report Code: MD 2843 Feb, 2021, by marketsandmarkets.com

[164 Pages Report] The global clinical chemistry analyzers market size is projected to reach USD 15.2 billion by 2026 from USD 12.3 billion in 2021, at a CAGR of 4.3%. Market growth is driven by the rising geriatric population and the increasing prevalence of chronic & lifestyle diseases, growing adoption of Point-of-Care testing devices and rising demand for laboratory automation.

Clinical Chemistry Analyzers Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on Global Clinical Chemistry Analyzers Market

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has moved from a regional crisis to a global pandemic in just a matter of a few weeks. The COVID-19 pandemic negatively affected sales of the companies. Lockdowns resulting from the COVID-19 pandemic caused people to delay undergoing health checkups, thus affecting the number of tests being performed and sales of reagents. However, a resurgence in testing numbers is seen as countries gradually ease restrictions on movement. With the COVID-19 pandemic, responding to infectious disease has become a pressing medical issue worldwide. In addition to the development of vaccines and therapeutic drugs, there is a growing call for the development of more precise and simple testing technologies and the expansion of testing structures. COVID-19 has also impacted the regulatory environment and practices, as governments and healthcare providers face unprecedented challenges. Regulatory authorities utilized methods to speed approval of diagnostic products. Companies have taken strategic developments to introduce COVID-19 rapid tests, sustain their revenues, and nullify the impact of COVID-19 on their operational capabilities

Market Dynamics

Driver: Rising geriatric population and the increasing prevalence of chronic & lifestyle diseases

The rising geriatric population in developed and developing regions will positively influence the growth of the clinical chemistry analyzers market. Due to rapid growth in the senior population, the prevalence of age-associated diseases such as hypertension, diabetes, cardiovascular, liver, and kidney diseases are expected to increase significantly. The diagnosis and management of such diseases are responsible for the increasing number of prescriptions for tests such as basic metabolic panel, lipid profile, and liver & renal panel.The rise in chronic illnesses will increase the demand for tests prescribed for the prevention, diagnosis, and treatment for the same. These factors, alongside the growing trend for preventive medicine, is expected to drive the demand for clinical chemistry analyzers during the forecast period. These tests are performed by clinical chemistry analyzers; hence, it is expected to have a positive impact on this market.

Opportunity: Increasing government initiatives and funding for preventive care

The government initiatives, schemes, or funding that supports and promotes the innovation and development of the diagnostics market provides growth opportunities in the clinical chemical analyzers market.

Restraint: The requirement of high capital investments and a shortage of skilled laboratory technicians

The high-volume clinical chemistry analyzers may be affordable only for large hospitals and reference laboratories with good capital budgets. Most small laboratories, physician’s offices, and sole practitioners have no capital budgets and may not be able to afford a large or very large-sized analyzer. Thus, the high fixed-cost requirements limit the growth of the clinical chemistry analyzers market.

At present, there is a significant shortage of laboratory technicians in both developed and developing nations. This is mainly attributed to the increasing patient population base, the retirement of elderly technicians, and the increasing number of cash-strapped colleges closing their clinical lab programs. Thus, there is a gap between the supply and demand of pathologists and lab technicians worldwide, therefore expecting to restrain the market growth.

In 2020, reagents segment accounted for the largest share of the clinical chemistry  analyzers market, by product

Based on product, the clinical chemistry analyzers market is segmented into analyzers, reagents and other products. The reagents segment accounted for the largest share in the clinical chemistry analyzers market in 2020. The recurrent requirement of reagents in large numbers as compared to analyzers is the major factor driving the growth of this segment.

In 2020, basic metabolic panel tests segment accounted for the largest share in the market, by test type

The clinical chemistry analyzers market is segmented into basic metabolic panels, electrolyte panels, liver panels, lipid profiles, renal profiles, thyroid function panels, and specialty chemical tests based on test type. In 2020, the basic metabolic panel tests segment accounted for the largest share. This can be attributed to the rising incidence of diabetes and other lifestyle & chronic diseases and the increasing trend of preventive healthcare.

North America is the largest regional market for clinical chemistry  analyzersa

The global clinical chemistry analyzers market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the global clinical chemistry analyzers market. The North American clinical chemistry analyzers market's growth can be attributed to the increasing geriatric population, increasing prevalence of chronic & lifestyle conditions, implementation of favorable government initiatives, increasing healthcare expenditure, improved healthcare infrastructure, and the availability of technologically advanced instruments.

Clinical Chemistry Analyzers Market   by Region

Scope of the report

Report Metric

Details

Market size available for years

2019–2026

Base year considered

2020

Forecast period

2021–2026

Forecast units

Value (USD Billion)

Segments covered

Product, test type, end user, and region

Geographies covered

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Companies covered

F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), HORIBA Ltd. (Japan), Sysmex Corporation (Japan), HITACHI (Japan), EKF Diagnostics (UK), Ortho Clinical Diagnostics (US), ELITech Group (France), Mindray Medical International Ltd. (China), BIOBASE Group (China), SFRI Medical Diagnostics (France), Trivitron Healthcare Pvt. Ltd. (India), Randox Laboratories Ltd. (UK), Medica Corporation (US), Meril Life Sciences Pvt. Ltd. (India), Erba Mannheim (UK), Genrui Biotech Inc. (China), DIRUI Industrial Co. Ltd. (China), Teco Diagnostics (US), Balio Diagnostics (France), Snibe Co. Ltd. (China), and AMS Alliance (Italy)

This report categorizes the clinical chemistry analyzers market into the following segments and subsegments:

By Product

  • Reagents
  • Analyzers
  • Other Products

By Test Type

  • Basic Metabolic Panels
  • Liver Panels
  • Renal Panels
  • Lipid Profiles
  • Thyroid Function Panels
  • Electrolyte Panels
  • Specialty Chemical Tests

By End User

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Research Laboratories & Institutes
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe (RoE)
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
  • Middle East & Africa

Recent Developments

  • In January 2020, Sysmex invested in Astrego Diagnostics for the development of urinalysis solutions.
  • In November 2017, Roche Diagnostics acquired Viewics (US) to expand its leading position in the integrated core lab space with business analytics capabilities.
  • In December 2018, BIOBASE Group launched BK200 mini auto chemistry analyzer for small laboratories and clinics to meet the needs of its customers.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 24)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           FIGURE 1 INCLUSIONS & EXCLUSIONS
           1.2.1 MARKETS COVERED
           FIGURE 2 CLINICAL CHEMISTRY ANALYZERS MARKET
           1.2.2 YEARS CONSIDERED FOR THE STUDY
    1.3 CURRENCY
    1.4 LIMITATIONS
    1.5 STAKEHOLDERS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 29)
    2.1 RESEARCH DATA
    2.2 RESEARCH APPROACH
           FIGURE 3 CLINICAL CHEMISTRY ANALYZERS MARKET: RESEARCH DESIGN METHODOLOGY
           2.2.1 SECONDARY DATA
                    2.2.1.1 Key data from secondary sources
           2.2.2 PRIMARY DATA
           FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
                    2.2.2.1 Key data from primary sources
    2.3 MARKET SIZE ESTIMATION
           2.3.1 BOTTOM-UP APPROACH
           FIGURE 5 CLINICAL CHEMISTRY ANALYZERS MARKET: BOTTOM-UP APPROACH
           2.3.2 TOP-DOWN APPROACH
           FIGURE 6 CLINICAL CHEMISTRY ANALYZER MARKET: TOP-DOWN APPROACH
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 7 DATA TRIANGULATION METHODOLOGY
    2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 38)
           FIGURE 8 CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
           FIGURE 9 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
           FIGURE 10 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021 VS. 2026 (USD MILLION)
           FIGURE 11 CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
           FIGURE 12 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 42)
    4.1 CLINICAL CHEMISTRY ANALYZERS MARKET OVERVIEW
           FIGURE 13 THE RISING ADOPTION OF POC PRODUCTS IS EXPECTED TO SUPPORT MARKET GROWTH DURING THE FORECAST PERIOD
    4.2 CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
           FIGURE 14 THE REAGENTS SEGMENT IS EXPECTED TO COMMAND THE LARGEST SHARE OF THE MARKET, BY PRODUCT, IN 2021
    4.3 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
           FIGURE 15 THE SEMI-AUTOMATIC ANALYZER SEGMENT IS EXPECTED TO HOLD THE LARGEST SHARE OF THE MARKET, BY TYPE, DURING THE FORECAST PERIOD
    4.4 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2021 VS. 2026
           FIGURE 16 THE ASIA PACIFIC MARKET IS ESTIMATED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 45)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 17 CLINICAL CHEMISTRY ANALYZER MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS
           5.2.1 DRIVERS
                    5.2.1.1 Rising geriatric population and the increasing prevalence of chronic & lifestyle diseases
           TABLE 1 ESTIMATED INCREASE IN THE GERIATRIC POPULATION, BY REGION (2019-2050)
                    5.2.1.2 Growing adoption of Point-of-Care testing devices
                    5.2.1.3 Increasing demand for laboratory automation
           5.2.2 RESTRAINTS
                    5.2.2.1 The requirement of high capital investments and a shortage of skilled laboratory technicians
                    5.2.2.2 Availability of refurbished analyzers
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing government initiatives and funding for preventive care
           5.2.4 TRENDS
                    5.2.4.1 Multichannel operations of integrated analyzers
           5.2.5 COVID 19 IMPACT ANALYSIS
    5.3 PRICING ANALYSIS
           TABLE 2 AVERAGE SELLING PRICES OF PRODUCTS (USD)
    5.4 VALUE CHAIN ANALYSIS
           FIGURE 18 VALUE CHAIN ANALYSIS OF THE CLINICAL CHEMISTRY ANALYZERS MARKET
    5.5 PATENT ANALYSIS
    5.6 SUPPLY CHAIN ANALYSIS
           FIGURE 19 SUPPLY CHAIN ANALYSIS
    5.7 ECOSYSTEM ANALYSIS
    5.8 REGULATORY LANDSCAPE
           5.8.1 NORTH AMERICA
                    5.8.1.1 US
                    5.8.1.2 Canada
           5.8.2 EUROPE
           5.8.3 ASIA PACIFIC
                    5.8.3.1 China
                    5.8.3.2 Japan
                    5.8.3.3 India
           5.8.4 LATIN AMERICA
                    5.8.4.1 Brazil
                    5.8.4.2 Mexico
           5.8.5 MIDDLE EAST
           5.8.6 AFRICA
    5.9 PORTER’S FIVE FORCES ANALYSIS
           FIGURE 20 PORTER’S FIVE FORCES ANALYSIS
           5.9.1 THREAT FROM NEW ENTRANTS
           5.9.2 THREAT FROM SUBSTITUTES
           5.9.3 BARGAINING POWER OF BUYERS
           5.9.4 BARGAINING POWER OF SUPPLIERS
           5.9.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
    5.10 PESTLE ANALYSIS
    5.11 TRADE ANALYSIS
           5.11.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
           TABLE 3 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2016-2020 (USD MILLION)

6 CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT (Page No. - 61)
    6.1 INTRODUCTION
           TABLE 4 CLINICAL CHEMISTRY REAGENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
    6.2 REAGENTS
           6.2.1 THE RECURRENT PURCHASE REQUIREMENT OF REAGENTS DRIVES MARKET GROWTH
           TABLE 5 CLINICAL CHEMISTRY REAGENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
    6.3 ANALYZERS
           TABLE 6 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 7 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.3.1 SEMI-AUTOMATIC ANALYZERS
                    6.3.1.1 The cost-effectiveness of semi-automatic analyzers drives segment growth
           TABLE 8 SEMI-AUTOMATIC ANALYZERS MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.3.2 FULLY AUTOMATIC ANALYZERS
                    6.3.2.1 Fully automatic analyzers offer rapid sample processing, thus enhancing workflows
           TABLE 9 FULLY AUTOMATIC ANALYZERS MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.3.3 POINT-OF-CARE ANALYZERS
                    6.3.3.1 The increasing adoption of PoC technologies drives segment growth
           TABLE 10 POINT-OF-CARE ANALYZERS MARKET, BY REGION, 2019–2026 (USD MILLION)
    6.4 OTHER PRODUCTS
           TABLE 11 CLINICAL CHEMISTRY ANALYZERS FOR OTHER PRODUCTS MARKET, BY REGION, 2019–2026 (USD MILLION)

7 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE (Page No. - 67)
    7.1 INTRODUCTION
           TABLE 12 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
    7.2 BASIC METABOLIC PANEL
           7.2.1 THE RISING INCIDENCE OF DIABETES AND OTHER CHRONIC DISEASES IS A PRIMARY GROWTH DRIVER FOR THIS SEGMENT
           TABLE 13 BASIC METABOLIC PANEL TESTS MARKET, BY REGION, 2019–2026 (USD MILLION)
    7.3 LIVER PANEL
           7.3.1 THE INCREASING INCIDENCE OF LIVER-RELATED DISEASES IS A KEY FACTOR DRIVING MARKET GROWTH
           TABLE 14 LIVER PANEL TESTS MARKET, BY REGION, 2019–2026 (USD MILLION)
    7.4 RENAL PROFILE
           7.4.1 THE RISING INCIDENCE OF ESRD PATIENTS DRIVES THE GROWTH OF THE RENAL PROFILE TESTING MARKET
           TABLE 15 RENAL PROFILE TESTS MARKET, BY REGION, 2019–2026 (USD MILLION)
    7.5 LIPID PROFILE
           7.5.1 LIPID PROFILE TESTS ARE PRESCRIBED TO MONITOR UNHEALTHY LIPID LEVELS AND AVOID CVD RISKS
           TABLE 16 LIPID PROFILE TESTS MARKET, BY REGION, 2019–2026 (USD MILLION)
    7.6 THYROID FUNCTION PANEL
           7.6.1 THE INCREASING INCIDENCE OF THYROID-RELATED DISORDERS DRIVES THE GROWTH OF THIS SEGMENT
           TABLE 17 THYROID FUNCTION PANEL TESTS MARKET, BY REGION, 2019–2026 (USD MILLION)
    7.7 ELECTROLYTE PANEL
           7.7.1 THE ELECTROLYTE TEST PANEL IS PRESCRIBED TO PATIENTS THAT SUFFER FROM HYPERTENSION OR LIVER & KIDNEY DISEASES
           TABLE 18 ELECTROLYTE PANEL TESTS MARKET, BY REGION, 2019–2026 (USD MILLION)
    7.8 SPECIALTY CHEMICAL TESTS
           7.8.1 THIS SEGMENT IS EXPECTED TO GROW AT THE LOWEST CAGR DURING THE FORECAST PERIOD AS THESE TESTS ARE NOT PRESCRIBED REGULARLY
           TABLE 19 SPECIALTY CHEMICAL TESTS MARKET, BY REGION, 2019–2026 (USD MILLION)

8 CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER (Page No. - 75)
    8.1 INTRODUCTION
           TABLE 20 CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION)
    8.2 HOSPITALS AND CLINICS
           8.2.1 HOSPITALS ARE THE MAJOR END USERS OF CLINICAL CHEMISTRY ANALYZERS
           TABLE 21 CLINICAL CHEMISTRY ANALYZERS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2019–2026 (USD MILLION)
    8.3 DIAGNOSTIC LABORATORIES
           8.3.1 INCREASING OUTSOURCING ACTIVITIES TO DIAGNOSTIC LABORATORIES FOR REDUCED COSTS DRIVE THE GROWTH OF THIS SEGMENT
           TABLE 22 CLINICAL CHEMISTRY ANALYZERS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2019–2026 (USD MILLION)
    8.4 RESEARCH LABORATORIES & INSTITUTES
           8.4.1 GROWTH IN FUNDING FOR LIFE SCIENCE RESEARCH IS A PRIMARY DRIVER FOR THIS END-USER SEGMENT
           TABLE 23 CLINICAL CHEMISTRY ANALYZERS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2019–2026 (USD MILLION)
    8.5 OTHER END USERS
           TABLE 24 CLINICAL CHEMISTRY ANALYZERS MARKET FOR OTHER END USERS,BY REGION, 2019–2026 (USD MILLION)

9 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION (Page No. - 80)
    9.1 INTRODUCTION
           TABLE 25 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2019–2026 (USD MILLION)
    9.2 NORTH AMERICA
           FIGURE 21 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET SNAPSHOT
           TABLE 26 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 27 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 28 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 29 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
           TABLE 30 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.2.1 US
                    9.2.1.1 Increasing cases of diabetes & obesity-related diseases is a key factor expected to drive market growth
           TABLE 31 US: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 32 US: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE,2019–2026 (USD MILLION)
           TABLE 33 US: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
           TABLE 34 US: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 The increasing prevalence of chronic & lifestyle diseases drives the market growth in Canada
           TABLE 35 CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 36 CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 37 CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
           TABLE 38 CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER2019–2026 (USD MILLION)
    9.3 EUROPE
           TABLE 39 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 40 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 41 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 42 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
           TABLE 43 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.1 UK
                    9.3.1.1 The increasing number of accredited clinical laboratories in the UK propels market growth for chemical analyzers
           TABLE 44 UK: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 45 UK: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 46 UK: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
           TABLE 47 UK: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.2 GERMANY
                    9.3.2.1 Increasing healthcare expenditure to drive market growth in Germany
           TABLE 48 GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 49 GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE,2019–2026 (USD MILLION)
           TABLE 50 GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
           TABLE 51 GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Rising R&D expenditure in France to drive market growth
           TABLE 52 FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 53 FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 54 FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
           TABLE 55 FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Age-related chronic conditions owing to a large geriatric population to drive market growth in Italy
           TABLE 56 ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 57 ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 58 ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
           TABLE 59 ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.5 SPAIN
                    9.3.5.1 Increasing prevalence of age-associated disorders to drive market growth in Spain
           TABLE 60 SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 61 SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 62 SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE,2019–2026 (USD MILLION)
           TABLE 63 SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.6 RUSSIA
                    9.3.6.1 Increasing access to quality healthcare will support market growth in Russia
           TABLE 64 RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT,2019–2026 (USD MILLION)
           TABLE 65 RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 66 RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
           TABLE 67 RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.7 REST OF EUROPE (ROE)
           TABLE 68 ROE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 69 ROE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 70 ROE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
           TABLE 71 ROE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.4 ASIA PACIFIC
           FIGURE 22 APAC: CLINICAL CHEMISTRY ANALYZERS MARKET SNAPSHOT
           TABLE 72 APAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 73 APAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 74 APAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 75 APAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
           TABLE 76 APAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.1 CHINA
                    9.4.1.1 China accounted for the largest share of the APAC market in 2020
           TABLE 77 CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 78 CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 79 CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE,2019–2026 (USD MILLION)
           TABLE 80 CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.2 JAPAN
                    9.4.2.1 A favorable regulatory framework to drive market growth in Japan
           TABLE 81 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 82 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 83 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE,2019–2026 (USD MILLION)
           TABLE 84 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Increasing private & public investments in the country’s healthcare system will drive market growth
           TABLE 85 INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 86 INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 87 INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
           TABLE 88 INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.4 REST OF ASIA PACIFIC (ROAPAC)
           TABLE 89 ROAPAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 90 ROAPAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 91 ROAPAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
           TABLE 92 ROAPAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.5 LATIN AMERICA
           TABLE 93 LATIN AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 94 LATIN AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 95 LATIN AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
           TABLE 96 LATIN AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.6 MIDDLE EAST AND AFRICA
           TABLE 97 MEA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 98 MEA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 99 MEA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019–2026 (USD MILLION)
           TABLE 100 MEA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 118)
     10.1 OVERVIEW
           FIGURE 23 KEY DEVELOPMENTS IN THE CLINICAL CHEMISTRY ANALYZERS MARKET
     10.2 MARKET SHARE ANALYSIS
           FIGURE 24 CLINICAL CHEMISTRY ANALYZERS MARKET SHARE, BY KEY PLAYER (2019)
     10.3 COMPANY EVALUATION QUADRANT
             10.3.1 LIST OF EVALUATED VENDORS
             10.3.2 STARS
             10.3.3 EMERGING LEADERS
             10.3.4 PERVASIVE PLAYERS
             10.3.5 PARTICIPANTS
           FIGURE 25 CLINICAL CHEMISTRY ANALYZERS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
     10.4 COMPETITIVE EVALUATION MATRIX FOR START-UPS (2019)
             10.4.1 PROGRESSIVE COMPANIES
             10.4.2 STARTING BLOCKS
             10.4.3 RESPONSIVE COMPANIES
             10.4.4 DYNAMIC COMPANIES
           FIGURE 26 CLINICAL CHEMISTRY ANALYZERS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS, 2019
     10.5 COMPETITIVE SCENARIO
             10.5.1 MARKET EVALUATION MATRIX, 2018-2020
           FIGURE 27 MARKET EVALUATION MATRIX, 2018-2020
             10.5.2 PRODUCT LAUNCHES
           TABLE 101 KEY PRODUCT LAUNCHES
             10.5.3 ACQUISITIONS
           TABLE 102 KEY ACQUISITIONS
             10.5.4 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
           TABLE 103 KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
             10.5.5 EXPANSIONS
           TABLE 104 KEY EXPANSIONS

11 COMPANY PROFILES (Page No. - 127)
(Business Overview, Products Offered, Recent Developments, and MnM View)* 
     11.1 ROCHE DIAGNOSTICS LTD.
           FIGURE 28 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2019)
     11.2 DANAHER CORPORATION
           FIGURE 29 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
     11.3 ABBOTT LABORATORIES
           FIGURE 30 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
     11.4 THERMO FISHER SCIENTIFIC INC.
           FIGURE 31 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2019)
     11.5 SIEMENS HEALTHINEERS AG
           FIGURE 32 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
     11.6 HORIBA, LTD.
           FIGURE 33 HORIBA LTD.: COMPANY SNAPSHOT (2019)
     11.7 SYSMEX CORPORATION
           FIGURE 34 SYSMEX CORPORATION: COMPANY SNAPSHOT (2019)
     11.8 EKF DIAGNOSTICS
           FIGURE 35 EKF DIAGNOSTICS: COMPANY SNAPSHOT
     11.9 HITACHI
           FIGURE 36 HITACHI LTD.: COMPANY SNAPSHOT (2019)
     11.10 ORTHO CLINICAL DIAGNOSTICS
     11.11 ELITECHGROUP
     11.12 MINDRAY MEDICAL INTERNATIONAL LTD.
     11.13 BIOBASE GROUP
     11.14 SFRI MEDICAL DIAGNOSTICS
     11.15 TRIVITRON HEALTHCARE PVT. LTD.
     11.16 RANDOX LABORATORIES LTD.
     11.17 MEDICA CORPORATION
     11.18 MERIL LIFE SCIENCES PVT. LTD.
     11.19 ERBA MANNHEIM
     11.20 GENRUI BIOTECH INC.
     11.21 DIRUI INDUSTRIAL CO., LTD.
     11.22 TECO DIAGNOSTICS
     11.23 BALIO DIAGNOSTICS
     11.24 SNIBE CO. LTD.
     11.25 AMS ALLIANCE
*Details on Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies. 

12 APPENDIX (Page No. - 158)
     12.1 INSIGHTS FROM INDUSTRY EXPERTS
     12.2 DISCUSSION GUIDE
     12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     12.4 AVAILABLE CUSTOMIZATIONS
     12.5 RELATED REPORTS
     12.6 AUTHOR DETAILS

This study involved four major activities in estimating the current size of the clinical chemistry analyzers market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size.  After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects.

The following is a breakdown of the primary respondents:

Clinical Chemistry Analyzers Market  Size, and Share

To know about the assumptions considered for the study,download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the clinical chemistry analyzers market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry have been identified through extensive secondary research
  • The revenues generated by leading players operating in the clinical chemistry analyzers market have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Global Clinical Chemistry Analyzers Market Size: Top-Down Approach

Clinical Chemistry Analyzers Market  Size,Top-Down Approach

Data Triangulation

After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, segment, and forecast the global clinical chemistry analyzers market by product, test type, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and trends)
  • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies2
  • To track and analyze company developments such as product launches, partnerships, expansions, and acquisitions in the clinical chemistry analyzers market
  • To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Country Information

  • Clinical Chemistry Analyzers market size and growth rate estimates for countries in the Rest of Europe, the Rest of Asia Pacific, Latin America, and Middle East & Africa

Company profiles

  • Additional fifteen company profiles of players operating in the clinical chemistry analyzers market
COVID-19

Get in-depth analysis of the COVID-19 impact on the Clinical Chemistry Analyzers Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Clinical Chemistry Analyzers Market

Request For Special Pricing
Report Code
MD 2843
Published ON
Feb, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Clinical Chemistry Analyzers Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home